IDEX BIOMETRICS ASA (IDEX.OL) Stock Balance Sheet
Europe - Euronext Oslo - OSL:IDEX - NO0013536078 - Common Stock
6.553 NOK
+0.43 (+6.97%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.06M | 2.01M | 11.35M | 16.12M | 33.76M | |||
| Receivables | 348.00K | 931.00K | 1.93M | 2.28M | 1.50M | |||
| Inventories | 5.64M | 5.55M | 6.38M | 4.45M | 1.23M | |||
| Other Current Assets | 489.00K | 765.00K | 648.00K | 986.00K | 851.00K | |||
| Total Current Assets | 7.54M | 9.26M | 20.31M | 23.84M | 37.35M | |||
| Non-Current Assets | ||||||||
| PPE Net | 95.00K | 415.00K | 2.59M | 2.65M | 1.66M | |||
| Goodwill | 0.00 | 0.00 | 968.00K | 968.00K | 968.00K | |||
| Intangibles | 497.00K | 569.00K | 1.01M | 1.49M | 1.97M | |||
| Other Non-Current Assets | N/A | 1.00K | -1.00K | N/A | N/A | |||
| Total Non-Current Assets | 649.00K | 1.04M | 4.65M | 5.18M | 4.68M | |||
| TOTAL ASSETS | 8.19M | 10.30M | 24.96M | 29.02M | 42.03M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 5.08M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 115.00K | 396.00K | 624.00K | 402.00K | 362.00K | |||
| Accrued Expenses | N/A | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 1.51M | 850.00K | 688.00K | 1.54M | 685.00K | |||
| Other Current Liabilities | 2.03M | 2.21M | 6.00M | 3.09M | 3.24M | |||
| Total Current Liabilities | 3.65M | 3.46M | 12.39M | 5.03M | 4.29M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.12M | 1.98M | 1.24M | 1.14M | 11.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 788.00K | 140.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.90M | 2.12M | 1.24M | 1.14M | 11.00K | |||
| TOTAL LIABILITIES | 5.55M | 5.58M | 13.63M | 6.17M | 4.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 8.05M | -344.48M | -330.03M | -303.40M | -1.24M | |||
| Additional Paid In Capital | 1.82M | 1.74M | 2.12M | 4.04M | 9.45M | |||
| Common Shares | 5.51M | 12.94M | 25.95M | 22.76M | 20.41M | |||
| Other Shareholders' Equity | -12.73M | 334.51M | 313.29M | 299.44M | 9.10M | |||
| Shares Outstanding | 56.91M | 8.32M | 2.80M | 2.34M | 2.03M | |||
| Tangible Book Value per Share | 0.04 | 0.50 | 3.34 | 8.73 | 17.11 | |||
| Total Shareholders' Equity | 2.64M | 4.71M | 11.33M | 22.84M | 37.73M | |||
| TOTAL LIABILITIES AND EQUITY | 8.19M | 10.30M | 24.96M | 29.02M | 42.03M | |||
| Statistics | ||||||||
| Debt/Equity | 0.42 | 0.42 | 0.56 | 0.05 | 0.00 | |||
| Current Ratio | 2.07 | 2.67 | 1.64 | 4.74 | 8.71 | |||
| Return On Assets (ROA) | -133.36% | -140.32% | -106.68% | -112.57% | -77.46% | |||
| Return On Equity (ROE) | -413.86% | -306.58% | -234.95% | -143.00% | -86.29% | |||
All data in USD (non-GAAP EPS in NOK ) , ROIC based on taxRate of 0.23